Home » Paddock Seeks Judgment Against Ethypharm on Patent
Paddock Seeks Judgment Against Ethypharm on Patent
Paddock Laboratories is suing Ethypharm to obtain a declaratory judgment of noninfringement in a dispute over a patent covering Antara capsules, a drug used to treat high cholesterol. Paddock notified Ethypharm in May that it had filed an ANDA to market a generic version of Antara (fenofibrate) in 43- and 130-mg strengths. The ANDA included a Paragraph IV certification on the ’574 patent, but Ethypharm didn’t file a patent infringement lawsuit during the 45-day period mandated by the Hatch-Waxman Act, according to court documents.
Generic Line
Generic Line
Upcoming Events
-
07May
-
14May
-
23May
-
30May
-
21Oct